232 related articles for article (PubMed ID: 9866400)
1. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
Adambekov DA; Litvinov VI; Mambetov KB; Koshmuratov AG; Sabyrbekova TS
Probl Tuberk; 1998; (5):46-8. PubMed ID: 9866400
[TBL] [Abstract][Full Text] [Related]
2. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
Karachunskiĭ MA; Gergert VIa; Iakovleva OB
Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
Chukanov VI; Gergert VIa; Khomenko IS
Probl Tuberk; 1989; (6):30-3. PubMed ID: 2771908
[TBL] [Abstract][Full Text] [Related]
4. [Effects of sodium nucleinate on immunological and nonspecific responsiveness in elderly and senile patients].
Adambekov DA; Litvinov VI; Koshmuratov AG; Mambetov KB; Sabyrbekova TS
Probl Tuberk; 1999; (4):27-30. PubMed ID: 10479929
[TBL] [Abstract][Full Text] [Related]
5. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
Mel'nik VP
Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
[TBL] [Abstract][Full Text] [Related]
6. [T-activin in the complex treatment of patients with pulmonary tuberculosis].
Ivanova LA; Pavlova MV
Probl Tuberk; 1986; (5):37-40. PubMed ID: 3488548
[No Abstract] [Full Text] [Related]
7. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
Ivanova LA
Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
[TBL] [Abstract][Full Text] [Related]
9. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
Sakhelashvili-Haladzhun MI
Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
[TBL] [Abstract][Full Text] [Related]
10. [The electrophoretic mobility of peripheral blood lymphocytes in patients with tuberculosis of the lungs].
Skvortsova RG; Nikitina OI
Probl Tuberk; 1990; (5):11-4. PubMed ID: 2388887
[TBL] [Abstract][Full Text] [Related]
11. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
[No Abstract] [Full Text] [Related]
12. [Prevention of side effects of specific chemotherapy in patients with pulmonary tuberculosis].
Batian AN; Abramovskaia AK; Batian ON
Probl Tuberk; 1991; (7):60-2. PubMed ID: 1754594
[TBL] [Abstract][Full Text] [Related]
13. [Tactivin in combined treatment of patients with pulmonary tuberculosis associated with gastrointestinal diseases].
Zhukova EM
Probl Tuberk; 1995; (3):25-7. PubMed ID: 7617628
[TBL] [Abstract][Full Text] [Related]
14. [Immunological correction in progressive pulmonary tuberculosis].
Maslennikov AA; Kamenev VF; Kolomiets VM
Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of antitubercular chemotherapy combined with corticosteroids and immunomodulators].
Khomenko IS; Chukanov VI; Gergert VIa; Utkin VV
Probl Tuberk; 1990; (1):24-8. PubMed ID: 2336431
[TBL] [Abstract][Full Text] [Related]
16. [Changes in the production of interleukin-1 beta, tumor necrosis factor-alpha and interleukin-2 in relation to the immunity in patients with pulmonary tuberculosis].
Knoring VE; Simbirtsev AS; Sakharova IIa; Rekstina TA; Davydova NI; Kotov AIu; Kalinina NM; Pigareva NV; Leonchenko EM
Probl Tuberk; 1999; (4):31-5. PubMed ID: 10479931
[TBL] [Abstract][Full Text] [Related]
17. [The clinical significance of changes in CD4+ T cell counts by peripheral blood from patients with pulmonary tuberculosis after antitubercular treatment].
Li DX; Zhang TT; Tan SY; Xiao P; Tan YJ; Zhang XL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):679-81, 684. PubMed ID: 20619093
[TBL] [Abstract][Full Text] [Related]
18. [Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin].
Chuvirov GN; Markova TP
Ter Arkh; 1986; 58(9):67-70. PubMed ID: 3787495
[TBL] [Abstract][Full Text] [Related]
19. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].
Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
Probl Tuberk; 1991; (12):52-4. PubMed ID: 1803376
[TBL] [Abstract][Full Text] [Related]
20. [T-lymphocyte subpopulations in autoimmune and subacute thyroiditis treated with T-activin].
Sakaeva NA; Balabolkin MI; Tabagari DZ
Sov Med; 1989; (10):39-41. PubMed ID: 2617340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
